|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5299 USD | +2.89% |
|
+2.04% | +17.76% |
| 04-06 | Zivo Bioscience Inc Signs Manufacturing Agreement with Cyanotech Corporation for Zivolife Algal Biomass | CI |
| 11-12 | Cyanotech Corporation, Q2 2026 Earnings Call, Nov 11, 2025 |
| Market Cap | 2.17M 1.9M 1.75M 1.62M 3.08M 207M 3.13M 20.97M 8.23M 102M 8.17M 7.99M 351M | P/E 2024 |
-0.36x | P/E 2025 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 13.48M 11.79M 10.88M 10.05M 19.06M 1.29B 19.38M 130M 51.04M 633M 50.62M 49.52M 2.18B | EV / Sales 2024 |
0.53x | EV / Sales 2025 | 0.57x |
| Free-Float |
67.23% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Cyanotech Corporation
| 1 day | +2.89% | ||
| 1 week | +2.04% | ||
| Current month | +22.07% | ||
| 1 month | +35.87% | ||
| 3 months | +65.59% | ||
| 6 months | +5.98% | ||
| Current year | +17.76% |
| 1 week | 0.47 |  | 0.53 |
| 1 month | 0.39 | | 0.53 |
| Current year | 0.23 | | 0.55 |
| 1 year | 0.21 | | 0.57 |
| 3 years | 0.12 | | 1.04 |
| 5 years | 0.12 | | 3.95 |
| 10 years | 0.12 | | 6.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Custer
CEO | Chief Executive Officer | 43 | 15/06/2022 |
Gerald Cysewski
CEO | Chief Executive Officer | 77 | 30/03/2016 |
| Director of Finance/CFO | 46 | 20/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
David Vied
BRD | Director/Board Member | 65 | 26/01/2015 |
David Mulder
BRD | Director/Board Member | 65 | 16/05/2016 |
Matthew Custer
BRD | Director/Board Member | 43 | 15/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/09/25 | Free | Chief Financial Officer | 50,000 | 0.6987% | ||
| 27/08/25 | Free | Director | 50,000 | 0.6987% | ||
| 27/08/25 | Free | Director | 50,000 | 0.6987% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.89% | +2.04% | +15.20% | -40.46% | 3.73M | |
| -2.69% | -1.47% | +49.55% | +160.93% | 1,085B | |
| -1.00% | -1.34% | +62.25% | +60.39% | 624B | |
| -1.24% | -3.69% | +25.82% | +82.43% | 442B | |
| +0.33% | -1.17% | +27.98% | +26.90% | 332B | |
| -3.89% | -11.22% | +20.78% | +26.07% | 277B | |
| -0.02% | -2.85% | +25.27% | +44.88% | 282B | |
| +0.66% | -1.42% | -29.26% | -39.30% | 217B | |
| -0.39% | -1.18% | +20.55% | +61.13% | 196B | |
| -3.43% | -0.17% | +12.97% | +70.95% | 167B | |
| Average | -0.95% | -1.09% | +23.11% | +45.39% | 362.19B | |
| Weighted average by Cap. | -1.61% | -1.06% | +34.80% | +80.86% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 23.07M 20.18M 18.61M 17.19M 32.62M 2.2B 33.17M 222M 87.34M 1.08B 86.62M 84.74M 3.73B | 24.22M 21.18M 19.54M 18.04M 34.24M 2.31B 34.81M 233M 91.67M 1.14B 90.92M 88.94M 3.91B |
| Net income | -5.27M -4.61M -4.25M -3.92M -7.45M -502M -7.57M -50.77M -19.94M -247M -19.78M -19.35M -851M | -3.2M -2.8M -2.58M -2.39M -4.53M -305M -4.6M -30.88M -12.13M -150M -12.03M -11.76M -517M |
| Net Debt | 10.2M 8.92M 8.23M 7.6M 14.42M 973M 14.66M 98.3M 38.6M 479M 38.29M 37.45M 1.65B | 11.31M 9.89M 9.12M 8.43M 15.99M 1.08B 16.26M 109M 42.8M 531M 42.45M 41.53M 1.83B |
Employees
83
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | US$0.5299 | +2.89% | 4,474 |
| 09/07/26 | US$0.5150 | -0.79% | 1,040 |
| 08/07/26 | US$0.5191 | -0.04% | 1,000 |
| 07/07/26 | US$0.5193 | +6.72% | 1,002 |
| 01/07/26 | US$0.4866 | +12.10% | 100 |
- Stock Market
- Stocks
- CYAN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
